Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB

Abstract

Histone deacetylase (HDAC) inhibitors induce growth arrest and apoptosis in a variety of human cancer cells. Sodium butyrate (NaB), a short chain fatty acid, is a HDAC inhibitor and is produced in the colonic lumen as a consequence of microbial degradation of dietary fibers. In order to dissect out the mechanism of NaB-induced growth inhibition of cancer cells, we carried out expression profiling of a human lung carcinoma cell line (H460) treated with NaB using a cDNA microarray. Of the total 1728 genes analysed, there were 32 genes with a mean expression value of 2.0-fold and higher and 66 genes with a mean expression value 3.0-fold and lower in NaB-treated cells. For a few selected genes, we demonstrate that their expression pattern by semiquantitative reverse transcription–polymerase chain reaction (RT–PCR) analysis is matching with the results obtained by microarray analysis. Closer view at the expression profile of NaB-treated cells revealed the downregulation of a total of 16 genes associated with cytokine signaling, in particular, interferon γ (IFNγ) pathway. In good correlation, NaB-pretreated cells failed to induce interferon regulatory factor 1, an INFγ target gene, efficiently upon IFNγ addition. These results suggest that NaB inhibits proinflammatory cytokine signaling pathway, thus providing proof of mechanism for its anti-inflammatory activity. We also found that NaB induced three genes, which are known metastatic suppressors, and downregulated 11 genes, which have been shown to promote metastasis. Upregulation of metastatic suppressor Kangai 1 (KAI1) by NaB in a time-dependent manner was confirmed by RT–PCR analysis. The differential regulation of metastasis-associated genes by NaB provides explanation for the anti-invasive properties of NaB. Therefore, our study presents new evidence for pathways regulated by NaB, thus providing evidence for the mechanism behind anti-inflammatory and antimetastatic activities of NaB.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Abbreviations

NaB, sodium butyrateIFNγ, interferon gammaIRF1:

interferon regulatory factor 1

References

  • Ailenberg M and Silverman M . (2002). Biochem. Biophys. Res. Commun., 298, 110–115.

  • Andoh A, Bamba T and Sasaki M . (1999). J. Parenter. Enteral. Nutr., 23, 70–73.

  • Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA and MacDonald TT . (1993). Immunology, 78, 127–131.

  • Bugaut M and Bentejac M . (1993). Annu. Rev. Nutr., 13, 217–241.

  • Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA and Richon VM . (2000). Cancer Res., 60, 5165–5170.

  • Chai F, Evdokiou A, Young GP and Zalewski PD . (2000). Carcinogenesis, 21, 7–14.

  • Chambers AF, Groom AC and MacDonald IC . (2002). Nat. Rev. Cancer, 8, 563–572.

  • Chang C and Werb Z . (2001). Trends Cell Biol., 11, S37–S43.

  • Charollais RH, Buquet C and Mester J . (1990). J. Cell. Physiol., 145, 46–52.

  • Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R and Childs G . (1999). Nat. Genet., 21, 15–19.

  • Clark EA, Golub TR, Lander ES and Hynes RO . (2000). Nature, 406, 532–535.

  • Clarke KO, Feinman R and Harrison LE . (2001). Cancer Lett., 171, 57–65.

  • Cummings JH . (1981). Gut, 22, 763–779.

  • Darnell Jr JE, Kerr IM and Stark GR . (1994). Science, 264, 1415–1421.

  • Das S, El-Deiry WS and Somasundaram K . (2003a). J. Biol. Chem., 278, 18313–18320.

  • Das S, El-Deiry WS and Somasundaram K . (2003b). Oncogene, 22, 8394–8402.

  • Decker T and Kovarik P . (2000). Oncogene, 19, 2628–2637.

  • DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA and Trent JM . (1996). Nat. Genet., 14, 457–460.

  • Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Issacs JT and Barrett JC . (1995). Science, 268, 884–886.

  • Eisen MB, Spellman PT, Brown PO and Botstein D . (1998). Proc. Natl. Acad. Sci. USA, 95, 14863–14868.

  • Fais S, Capobianchi MR, Pallone F, Di Marco P, Boirivant M, Dianzani F and Torsoli A . (1991). Gut, 32, 403–407.

  • Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C and Strober W . (1996). J. Immunol., 157, 1261–1270.

  • Gore SD and Carducci MA . (2000). Exp. Opin. Invest. Drugs, 9, 2923–2934.

  • Gray GG and Ekstrom TJ . (2001). Exp. Cell Res., 262, 75–83.

  • Iacomino G, Tecce MF, Grimaldi C, Tosto M and Russo GL . (2001). Biochem. Biophys. Res. Commun., 285, 1280–1289.

  • Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW and Giardina C . (2000). Gastroenterology, 118, 724–734.

  • Jove R . (2000). Oncogene, 19, 2466–2467.

  • Kano A, Haruyama T, Akaike T and Watanabe Y . (1999). Biochem. Biophys. Res. Commun., 257, 672–677.

  • Kawamata H, Kawai K, Kameyama S, Johnson MD, Stetler-Stevenson WG and Oyasu R . (1995). Int. J. Cancer, 63, 680–687.

  • Khochbin S, Verdel A, Lemercier C and Seigneurin-Berny D . (2001). Curr. Opin. Genet. Dev., 11, 162–166.

  • Kim MS, Son MW, Kim WB, In Park Y and Moon A . (2000). Cancer Lett., 157, 23–30.

  • Klampfer L, Huang J, Sasazuki T, Shirasawa S and Augenlicht L . (2003). Mol. Cancer Res., 1, 855–862.

  • Lallemand F, Courilleau D, Sabbah M, Redeuilh G and Mester J . (1996). Biochem. Biophys. Res. Commun., 229, 163–169.

  • Leary JA, Kerr J, Chenevix-Trench G, Doris CP, Hurst T, Houghton CR and Friedlander ML . (1995). Int. J. Cancer, 64, 189–195.

  • Lehninger AL, Nelson DL and Cox MM . (1993). Principles of Biochemistry 2nd edn Worth: New York.

    Google Scholar 

  • Liu LT, Chang HC, Chiang LC and Hung WC . (2003). Cancer Res., 63, 3069–3072.

  • Luhrs H, Gerke T, Muller JG, Melcher R, Schauber J, Boxberge F, Scheppach W and Menzel T . (2002a). Scand. J. Gastroenterol., 37, 458–466.

  • Luhrs H, Kudlich T, Neumann M, Schauber J, Melcher R, Gostner A, Scheppach W and Menzel TP . (2002b). Anticancer Res., 22, 1561–1568.

  • Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ . (1999). Am. J. Pathol., 155, 739–752.

  • Marks PA, Richon VM and Rifkind RA . (2000). J. Natl. Cancer Inst., 92, 1210–1216.

  • Masuda T, Saito H, Kaneko F, Atsukawa K, Morita M, Inagaki H, Kumagai N, Tsuchimoto K and Ishii AH . (2000). In vitro Cell Dev. Biol. Anim., 36, 387–394.

  • Mcintosh GM, Leleu RK, Royle PJ and Young GP . (1996). J. Gastroenterol. Hepatol., 11, 113–119.

  • McIntyre AMC, Gibson PR and Young GP . (1993). Gut, 34, 386–391.

  • Medina V, Edmonds B, Young GP, James R, Appleton S and Zalewski PD . (1997). Cancer Res., 57, 3697–3707.

  • Miele ME, De La Rosa A, Lee JH, Hicks DJ, Dennis JU, Steeg PS and Welch DR . (1997). Clin. Exp. Metast., 15, 259–265.

  • Morita A, Tsao D and Kim YS . (1982). Cancer Res., 42, 4540–4545.

  • Pahl HL . (1999). Oncogene, 18, 6853–6866.

  • Pellizzaro C, Coradini D, Daniotti A, Abola OG and Daidone MG . (2001). Int. J. Cancer, 91, 654–657.

  • Phillips KK, White AE, Hicks DJ, Welch DR, Barrett JC, Wei LL and Weissman BE . (1998). Mol. Carcinogen., 21, 111–120.

  • Ranganna K, Yatsu FM, Hayes BE, Milton SG and Jayakumar A . (2000). Mol. Cell. Biochem., 205, 149–161.

  • Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA and Marks PA . (1998). Proc. Natl. Acad. Sci. USA, 95, 3003–3007.

  • Rinker-Schaeffer CW, Hawkins AL, Dong JT, Stoica G, Griffin CA, Ichikawa T, Barrett JC and Issacs JT . (1994). Cancer Res., 54, 6249–6256.

  • Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, Knuechel R, Baeuerle PA, Scholmerich J and Gross V . (1998). Gastroenterology, 115, 357–369.

  • Ruoslahti E . (1999). Adv. Cancer Res., 76, 1–20.

  • Saemann MD, Bohmig GA, Osterreicher CH, Burtscher H, Parolini O, Diakos C, Stockl J, Horl WH and Zlabinger GJ . (2000). FASEB J., 14, 2380–2382.

  • Schena M, Shalon D, Davis RW and Brown PO . (1995). Science, 270, 467–470.

  • Schreiber S, Nikolaus S and Hampe J . (1998). Gut, 42, 477–484.

  • Segain JP, Bletiere DR, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottiere HM and Galmiche JP . (2000). Gut, 47, 397–403.

  • Siavoshian S, Segain JP, Kornprobst M, Bonnet C, Cherbut C, Galmiche JP and Blottiere HM . (2000). Gut, 46, 507–514.

  • Tabuchi Y, Ohta S, Arai Y, Kawahara M, Ishibashi K, Sugiyama N, Horiuchi T, Furusawa M, Obinata M, Fuse H, Takeguchi N and Asano S . (2000). Cell Struct. Funct., 25, 297–307.

  • Tsao D, Morita A, Bella Jr A, Luu P and Kim YS . (1982). Cancer Res., 42, 1052–1058.

  • Urnov FD . (2003). J. Cell. Biochem., 88, 684–694.

  • Velazquez OC, Lederer HM and Rombeau JL . (1997). Adv. Exp. Med. Biol., 427, 123–134.

  • Wajapeyee N and Somasundaram K . (2003). J. Biol. Chem., 278, 52093–52101.

  • Wang J, Saunthararajah Y, Redner RL and Liu JM . (1999). Cancer Res., 59, 2766–2769.

  • Weidle UH and Grossmann A . (2000). Anticancer Res., 20, 1471–1486.

  • Whiteley LO, Higgins JM, Purdon MP, Ridder GM and Bertram TM . (1996). Dig. Dis. Sci., 41, 1458–1467.

  • Widmer J, Fassihi KS, Schlichter SC, Wheeler KS, Crute BE, King N, Nutile-Mcmenemy N, Noll WW, Daniel S, Ha J, Kim KH and Witters LA . (1996). Biochem. J., 316, 915–922.

  • Xiao H, Hasegawa T, Miyaishi O, Ohkusu K and Isobe K . (1997). Biochem. Biophys. Res. Commun., 237, 457–460.

  • Yim JH, Ro SH, Jennifer KL, Susan JW, Connett J and Doherty GM . (2003). J. Interferon Cytokine Res., 23, 501–511.

  • Yin L, Laevsky G and Giardina C . (2001). J. Biol. Chem., 276, 44641–44646.

Download references

Acknowledgements

This study was supported partly by funding from Indian Council of Medical Research, Government of India, ICMR Center for Advanced Study in Molecular Medical Microbiology and Department of Biotechnology, Government of India, as Program support. JJ is supported by a postdoctoral fellowship from Department of Biotechnology (DBT).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kumaravel Somasundaram.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joseph, J., Mudduluru, G., Antony, S. et al. Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene 23, 6304–6315 (2004). https://doi.org/10.1038/sj.onc.1207852

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207852

Keywords

This article is cited by

Search

Quick links